Research on Current Topics in AD/ADRD
Funds independent Alzheimer and dementia studies led by investigators across biological and clinical approaches.
PAR-25-332 is NIA's parent NOFO for investigator-initiated R01 research on current priority topics in AD/ADRD. Released December 30, 2024, expiring November 6, 2027. FY2026 policy applies a 16% average reduction on competing awards except for new investigators (NI/ESI).
AIBiotechMedtechNeurotech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.